Who we are

At Recordati Rare Diseases UK , we focus on those affected by rare diseases. We believe that every single patient has the right to the best possible treatment. Patients with rare diseases are our top priority. They are at the core of our planning, our thinking and our actions.

Recordati Rare Diseases UK is a pharmaceutical company that provides treatment for patients with rare diseases. Created in 1990 (as Orphan Europe), Recordati Rare Diseases is active in the field of rare diseases.

Our UK team have a personal commitment to improving the lives of people who have a rare disease. We recognise, that only through working collaboratively with all stakeholders, are we able to tackle the challenges in the orphan drug and rare disease field. These challenges include disease awareness, education and training, and the development of consensus around diagnostic and clinical care guidelines. Ultimately our aim is to improve the quality of life for people with rare diseases.

Recordati Rare Diseases is committed to supporting families affected by rare diseases through the research and development of innovative therapies and the distribution of specific scientific knowledge throughout the medical community.

To this end Recordati Rare Diseases seeks to introduce new products via discovery programmes as well as through alliances with other companies and with research institutes. A number of new products are in different stages of development for the treatment of rare diseases.